ALIROCUMAB (Praluent®)

Clinical Indication

Primary hypercholesterolaemia

Comments

In line with NICE TA 393

Local guidance

Moved from black traffic light end Sept 2016

Date of classification

September 2016

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.